Interactions of ketoprofen and ibuprofen with β-cyclodextrins in solution and in the solid state

被引:166
作者
Mura, P
Bettinetti, GP
Manderioli, A
Faucci, MT
Bramanti, G
Sorrenti, M
机构
[1] Univ Florence, Dipartimento Sci Farmaceut, I-50121 Florence, Italy
[2] Univ Pavia, Dipartimento Chim Farmaceut, I-27100 Pavia, Italy
关键词
ibuprofen; ketoprofen; chemically modified beta-cyclodextrins; inclusion complexation; phase-solubility analysis; C-13; NMR; IR spectroscopy; differential scanning calorimetry; x-ray diffractometry; dissolution rate;
D O I
10.1016/S0378-5173(98)00035-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The complexing, solubilizing and amorphizing abilities towards ketoprofen and ibuprofen of native beta-cyclodextrin and some randomly substituted amorphous derivatives (methyl, hydroxyethyl, and hydroxypropyl beta-cyclodextrin with an average substitution degree per anhydroglucose unit, respectively of 1.8, 1.6 and 0.9) were determined and compared with those already observed for naproxen. Drug-carrier interactions were studied in aqueous solution by means of phase-solubility analysis and C-13 NMR spectroscopy, and in the solid state using differential scanning calorimetry (DSC), X-ray powder diffractometry and infrared spectroscopy. The strength of the inclusion complexes with beta-cyclodextrins (K-1:1,K-ibu, K-1:1,K-nap > K-1:1,K-keto) was directly related to the hydrophobic character of the guest (log P values) and depended on its molecular features. The presence in physical mixtures of a high-energy state of crystalline drug molecularly dispersed in the amorphous carrier was assumed from DSC, behaviour. Dissolution rates (dispersed amount method) of the active ingredient from equimolar drug-cyclodextrin physical mixtures and amorphous colyophilized products showed that methyl beta-cyclodextrin was the most effective carrier also for ketoprofen and ibuprofen. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:189 / 203
页数:15
相关论文
共 34 条
[1]   C-13 NUCLEAR-MAGNETIC-RESONANCE STUDY OF NAPROXEN INTERACTION WITH CYCLODEXTRINS IN SOLUTION [J].
BETTINETTI, G ;
MELANI, F ;
MURA, P ;
MONNANNI, R ;
GIORDANO, F .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (12) :1162-1170
[2]   THERMAL-BEHAVIOR AND DISSOLUTION PROPERTIES OF NAPROXEN IN COMBINATIONS WITH CHEMICALLY MODIFIED BETA-CYCLODEXTRINS [J].
BETTINETTI, G ;
GAZZANIGA, A ;
MURA, P ;
GIORDANO, F ;
SETTI, M .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1992, 18 (01) :39-53
[3]  
BETTINETTI GP, 1990, MINUTES OF THE FIFTH INTERNATIONAL SYMPOSIUM ON CYCLODEXTRINS, P239
[4]   KETOPROFENE [J].
BRIARD, P ;
ROSSI, JC .
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1990, 46 :1036-1038
[5]   PH-SOLUBILITY RELATIONSHIP AND PARTITION-COEFFICIENTS FOR SOME ANTI-INFLAMMATORY ARYLALIPHATIC ACIDS [J].
CHIARINI, A ;
TARTARINI, A ;
FINI, A .
ARCHIV DER PHARMAZIE, 1984, 317 (03) :268-273
[6]   CHARACTERIZATION, DISSOLUTION AND BIOAVAILABILITY IN RATS OF IBUPROFEN - BETA-CYCLODEXTRIN COMPLEX SYSTEM [J].
CHOW, DD ;
KARARA, AH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 28 (2-3) :95-101
[7]  
Connors K. A, 1987, BINDING CONSTANTS ME
[8]   MECHANISM OF DRUG DISSOLUTION RATE ENHANCEMENT FROM BETA-CYCLODEXTRIN-DRUG SYSTEMS [J].
CORRIGAN, OI ;
STANLEY, CT .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (10) :621-626
[9]   CYCLODEXTRIN ADAMANTANECARBOXYLATE INCLUSION COMPLEXES - STUDIES OF THE VARIATION IN CAVITY SIZE [J].
CROMWELL, WC ;
BYSTROM, K ;
EFTINK, MR .
JOURNAL OF PHYSICAL CHEMISTRY, 1985, 89 (02) :326-332
[10]   DISSOLUTION AND PARTITION THERMODYNAMIC FUNCTIONS OF SOME NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
FINI, A ;
LAUS, M ;
ORIENTI, I ;
ZECCHI, V .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (01) :23-25